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OBJECTIVEdAssociation between white blood cell (WBC) count and diabetes risk has been
recently suggested. We assessed whether WBC count is an independent risk factor for diabetes
incidence among young healthy adults.
RESEARCH DESIGN AND METHODSdWBC count was measured in 24,897 young
(mean age 30.8 6 5.36 years), normoglycemic men with WBC range of 3,000 to 12,000 cells/
mm
3. Participants were periodically screened for diabetes during a mean follow-up of 7.5 years.
RESULTSdDuring 185,354 person-years of follow-up, diabetes was diagnosed in 447 sub-
jects.Amultivariatemodeladjustedforage,BMI,familyhistoryofdiabetes,physicalactivity,and
fasting glucose and triglyceride levels revealed a 7.6% increase in incident diabetes for every
increment of 1,000 cells/mm
3 (P = 0.046). When grouped in quintiles, a baseline WBC count
above6,900cells/mm
3hadanindependent52%increaseindiabetesrisk(hazardratio1.52[95%
CI 1.06–2.18]) compared with the lowest quintile (WBC ,5,400 cells/mm
3). Men at the lowest
WBC quintile were protected from diabetes incidence even in the presence of overweight, family
historyofdiabetes,orelevatedtriglyceridelevels.Aftersimultaneouscontrolforriskfactors,BMI
wasthe primary contributor of the variation inmultivariate models (P, 0.001), followed by age
and WBC count (P , 0.001), and family history of diabetes and triglyceride levels (P = 0.12).
CONCLUSIONSdWBC count, a commonly used and widely available test, is an indepen-
dent risk factor for diabetes in young men at values well within the normal range.
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O
besity and type 2 diabetes are lead-
ing causes of morbidity and mor-
tality, and their prevalence is
increasingly rising in the younger popu-
lation (1). There is solid evidence to sup-
port low-grade inﬂammation as a key
component in the pathophysiology of
the metabolic syndrome and type 2 dia-
betes, linking adiposity and insulin resis-
tance (2). Inﬂammatory cells have been
shown to inﬁltrate the adipose tissue in
obese humans, associated with increased
production and secretion of inﬂamma-
tory cytokines that may contribute to
whole-body inﬂammation (3,4). Chronic
inﬂammation has been associated with
an increased incidence of diabetes even
in the absence of obesity (5,6), such as
in patients with rheumatoid arthritis
and psoriasis, and treatment with anti-
inﬂammatory medications in these con-
ditionssigniﬁcantly decreased the rates of
diabetes (7).
Several epidemiological studies (8–
11), but not all (12,13), have shown links
between variousmarkers of inﬂammation
and diabetes risk prediction, including
interleukin-6 (IL-6) and C-reactive protein
(CRP). Total peripheral white blood cells
(WBC) count, a nonspeciﬁc marker of in-
ﬂammation, has also been suggested to be
associated with diabetes risk in some co-
horts (14–16), but observations were not
consistent (10,17). A recent meta-analysis
of 20 studies including ;90,000 partici-
pants demonstrated a positive correlation
between increased WBC level and diabe-
tes risk (18). However, most studies in
this meta-analysis enrolled middle-aged
participants and were based on cross-
sectional data, with only partial adjust-
ments for other diabetes risk factors. In
addition, whether elevated inﬂammatory
markers can predict the risk for diabetes
independent of adiposity is not yet clear.
Although a few studies showed signiﬁcant
associationsbetweenCRPandincidentdi-
abetesafteradjustmentforobesityindexes
(8,9,19–21) others have argued that the
association is mediated entirely by in-
creased adiposity (11,13,17).
The aim of our study was to assess
whether an increased WBC count within
the normal range can predict diabetes
incidence in young adults. Using the
Metabolic, Life-style and Nutrition As-
sessment in Young adult (MELANY)
cohort, a large prospective, population-
based cohort, we report that an elevated
WBCcountinyoung,apparentlyhealthy,
normoglycemic men, already at levels
well within the normal range, is an in-
dependentpredictoroffuturediabetes.In
addition, men withknownrisk factors for
obesity, but with low-normal WBC
count, were relatively protected from
type 2 diabetes.
RESEARCH DESIGN AND
METHODS
Study population
The MELANY cohort has been conducted
at the Israel Defense Forces Staff Periodic
Examination Center (SPEC), to which all
career service personnel aged older than
25 years are referred every 3 to 5 years
for a routine health examination and
screening tests, as described previously
(22,23). At each visit to the SPEC, partic-
ipantscompletedadetailedquestionnaire
assessing demographic, nutritional, life-
style, and medical factors. Blood samples
weredrawnaftera14-hfastandimmediately
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ORIGINAL ARTICLEanalyzed. Height and weight were mea-
sured, and a physician at the center per-
formed a complete physical examination.
Primary care for all Israel Defense Forces
personnel between scheduled visits to the
center is obtained at designated military
clinics, and all medical information is re-
corded in the same central database,
thereby facilitating ongoing, tight, and
uniform follow-up.
This study assessed 37,418 men who
had documented WBC counts within the
normal range (3,000–12,000 cells/mm
3)
at their ﬁrst visit to the SPEC between the
years 1995 and 2010. The analysis ex-
cluded 1) men with pre-existing type 1
or type 2 diabetes, men with fasting
plasma glucose (FPG) level $100 mg/dL
at the ﬁrst visit (n = 3,638), or men with-
newly diagnosed diabetes (FPG $126
mg/dL, n =6 0 2 ) ;2) men with a follow-
up shorter than 2 years (n = 8,001); or 3)
men missing fasting glucose levels or
WBC count (n = 280). The institutional
review board of the Israel Defense Forces
MedicalCorpsapprovedthisstudyonthe
basisofstrictmaintenanceofparticipants’
anonymity during database analyses.
Follow-up and outcome
Participants aged 25 to 45 years were
followed up prospectively from their ﬁrst
visit to the SPEC until retirement from
military service. Follow-up ended at the
time of diabetes diagnosis, death, retire-
ment from military service, or 8 March
2011, whichever came ﬁrst. Mean total
follow-up was 7.71 6 3.83 years, corre-
sponding to ;85 and 67% completing at
least 3 and 5 years of follow-up, respec-
tively. All participants were censored at
the end of their follow-up period (based
ontheabovecriteriaforendoffollow-up);
thus, none of the study participants were
lost to follow-up. Of note, follow-up du-
ration for subjects who did and did not
develop diabetes was similar (7.72 6
2.84 and 7.44 6 3.84 years, respectively,
P=0.13),andbaselineWBClevelsdidnot
affect the number of visits to the SPEC.
Screening for diabetes was performed
at each visit to the SPEC using FPG. The
diagnosisof447incidentcasesofdiabetes
was based on the American Diabetes As-
sociation criteria by documenting two
FPG levels of $126 mg/dL (7.0 mmol/L)
or a glucose level $126 mg/dL 2 h after
ingestionof75gofglucose.Thediagnosis
was made after the abnormal screening
result at each visit to the SPEC in 198
subjects (44.3%) or between visits by
the participants’ Israeli Defense Force
primary care physician, followed by con-
ﬁrmation by a military physicians’ com-
mittee, in 249 (55.7%). All laboratory
studies were performed on fresh samples
in an International Organization for Stan-
dardization (ISO)-9002 quality-assured
core facility laboratory.
Statistical analysis
The cohort was divided into WBC quin-
tiles, and their baseline characteristics are
presented in Table 1. (Baseline character-
istics of patients who developed diabetes
vs. those who did not are detailed in Sup-
plementary Table 1.) The medians of the
quintiles were ﬁta sc o n t i n u o u sv a r i a b l e s
to estimate the trend of variables across
quintiles in a linear regression model (ad-
justed R
2 = 0.99, B = 900 cells/mm
3 per
quintile, P = 0.001). Cox proportional
hazard models were used to estimate the
hazard ratios (HR) and 95% CIs for de-
veloping diabetes. We gradually added to
the age-adjusted model (model 1) addi-
tional parameters known as classical risk
factors for diabetes (Table 2). In model 2,
BMIwasaddedasacontinuousvariable.In
model3,thefollowingcategoricalvariables
were added to model 2: smoking status
(current smoker, former smoker, never
smoked), family history of diabetes (yes
or no), and physical activity (not active,
,150 min/week, $150 min/week). In
model 4, serum triglyceride levels (quin-
tiles) and fasting glucose level (as continu-
ousvariables)wereaddedtothemodel.An
additionalmultivariatemodelwasconducted
analyzingWBCcountasacontinuousvar-
iable.Ofnote,thepresenceorabsenceofa
familyhistoryofdiabeteswasrecordedfor
each participant from the last available
visit to the examination center.
Log-minus-log plots for each variable
wereinspectedtoverifytheassumptionof
proportionality of the hazards. All vari-
ables used in the model were tested for
colinearity using the Pearson correlation.
The maximal R recorded was 0.357 (tri-
glyceride and BMI). Omnibus tests of
model coefﬁcients were used to assess
the relative contribution of the various
variables to the model. To evaluate the
power of the models to discriminate
events from nonevents we calculated the
area under the receiver operating charac-
teristic (ROC) curve for each of the var-
iablesaswellasinamultivariatemodel(C
statistic). To study potential threshold in
WBC count for diabetes prediction, a re-
stricted cubic spline (using R software)
and a decision tree procedure with CHAID
(x
2 Automatic Interaction Detection)
method were used. Values are reported as
mean 6 standard deviation (SD), unless
mentioned otherwise. Statistical analyses
were performed with SPSS 19.0 software.
RESULTS
Characteristics of study participants
Data of 24,897 apparently healthy young
normoglycemic men who were followed
up as part of the MELANY cohort met the
inclusion criteria. Participants were cate-
gorizedby quintiles accordingto theirWBC
count at enrollment. Baseline character-
istics are presented in Table 1. Mean WBC
count was 6,620 6 1,480 cells/mm
3
(range 3,000–12,000) with an average in-
crement of 900 cells/mm
3 between conse-
quent quintiles. WBC level was directly
correlated with BMI, systolic and diastolic
blood pressure, triglyceride level, LDL-
cholesterol, and rates of current smokers.
Physical activity and HDL cholesterol
were inversely correlated with WBC level
(P , 0.0001 for trend).
WBC count and risk for developing
diabetes
During185,354person-yearsoffollow-up,
447 new cases of diabetes were diagnosed
among young normoglycemic men. The
incidence of type 2 diabetes increased lin-
earlyacrossquintilesofWBC,with62new
cases diagnosed in the lowest quintile (Q1;
WBC of 3,000–5,400 cells/mm
3)a n d
124 new cases diagnosed in Q5 (WBC
.7,810). In model 1, adjusted for age,
t h er i s kf o rt y p e2d i a b e t e sw a s2 - f o l d
higher in Q4 (WBC 6,910–7,800 cells/
mm
3)and2.44-foldhigherinQ5compared
with Q1 (HR 2.44 [95% CI 1.79–3.31]).
Further adjustment for BMI (model 2, Ta-
ble 2) signiﬁcantly attenuated the risk for
diabetes associated with WBC levels.
Nevertheless, even in the multivariate
model adjusted for age, BMI, family his-
tory of diabetes, physical activity, triglyc-
eride level, and fasting glucose, WBC
count remained an independent risk fac-
tor of incident diabetes at levels .6,910
cells/mm
3 (model 4, Table 2), with a HR
in Q4 versus Q1 of 1.48 (1.03–2.14; P =
0.011 for trend). When WBC count was
modeled as a continuous variable, an in-
crement of 1,000 cells/mm
3 in WBC
count was associated with a 7.6% in-
crease in the risk for developing diabetes
independentlyofage,BMI,familyhistory
of diabetes, physical activity, triglyceride
level, and fasting glucose level (HR 1.076
[1.001–1.157], P = 0.046).
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adults using WBC count
To better assess the interrelation between
obesity and WBC, we next studied the
joint effect of BMI and WBC levels in
predicting the risk for developing type 2
diabetes (Fig. 1A). In a multivariate anal-
ysis controlled for age, family history of
diabetes, physical activity, triglyceride
level, and FPG, obese men (BMI $30
kg/m
2) with elevated WBC count within
thenormalrange(7,810–12,000cells/mm
3)
h a dam o r et h a ns i x f o l di n c r e a s ei nt h e
risk for type 2 diabetes (HR 6.1 [95% CI
3.81–9.78])comparedwiththereference
group.Ofinterest,astrongattenuationin
the risk for type 2 diabetes attributed to
overweight and obesity was observed
among individuals with low-normal
WBC (,5,400 cells/mm
3), reaching an
HR of 2.63 (1.19–5.88) for obese men
and a nonsigniﬁcant HR of 1.40 (0.8–
2.44) for overweight men. Taken to-
gether, these observations suggest that,
i nt h ep r e s e n c eo fal o w - n o r m a lW B C
count, overweight and obese men are
relatively protected from the develop-
ment of type 2 diabetes compared with
overweight or obese individuals with
higher WBC count.
Figure 1 demonstrates the joint ef-
fectsoftriglycerideslevel(Fig.1B)orfam-
ilyhistoryofdiabetes (Fig.1C)wit hWBC
count. Similar to the observation with
BMI, a relatively low WBC level (,5,400
cells/mm
3) was associated with complete
attenuation of diabetes risk attributed to
anelevatedtriglyceridelevelortoapositive
family history of diabetes.
We next assessed for a potential
threshold within the normal range of the
WBC count, above which diabetes risk
increases signiﬁcantly. Although a deci-
sion tree procedure (with CHAID) sug-
gested a WBC value of 7,230 cells/mm
3
as a potential cut point, no evidence for a
nonlinear component of WBC was ob-
served using restricted cubic splines
(data not shown). We therefore per-
formed the Cox regression multivari-
a t em o d e l su s i n gam o v i n gc u t o f fv a l u e
for WBC in increments as low as 100
cells/mm
3 (Supplementary Table 4). A
clear threshold could not be delineated;
however, the highest HR (1.438) with the
lowest P value (0.002) for diabetes inci-
dence was observed when the value of
7,100 cells/mm
3 was used. Of note, WBC
.7,100 cells/mm
3 corresponds exactly to
levels observed among the upper one-
third of the study population.
Residual contribution of WBC to
diabetes prediction
To assess the differential contribution of
the various risk factors to the prediction
of diabetes, we next calculated the ROC
curvesforWBCcountandforother,well-
validated diabetes risk factors. Surpris-
ingly, the AUC of the WBC count ROC
curve was not statistically different than
that of fasting glucose (0.59 [95% CI
0.55–0.61] vs. 0.58 [0.55–0.61], respec-
tively). BMI was the single most powerful
predictor for diabetes (AUC 0.670
[0.643–0.696]), followed by triglyceride
level(0.63[0.60–0.66]),WBCcount,and
fasting glucose. The addition of all
Table 1dBaseline characteristics of population cohort
Quintile of WBC count
Q1 Q2 Q3 Q4 Q5 All
n=5,269 n=4,963 n=5,423 n=4,499 n=4,743 N = 24,897 P
WBC count (cells/mm
3)3 , 0 0 0 –5,400 5,401–6,180 6,181–6,900 6,901–7,800 7,801–12,000 6,630 6 1,480
Age (years 6 SD) 30.5 6 5.27 30.7 6 5.28 30.7 6 5.30 31.0 6 5.43 31.4 6 5.51 30.8 6 5.36 ,0.0001
BMI (kg/m
2 6 SD) 24.09 6 3.32 24.84 6 3.47 25.39 6 3.74 25.87 6 3.97 26.64 6 4.3 25.33 6 3.86 ,0.0001
BMI (%)
,25 kg/m
2 65 56 50 45 38 52
25 to ,30 kg/m
2 30 36 39 40 42 37
$30 kg/m
2 5 8 11 15 20 11
BP (mmHg 6 SD)
Systolic 115.1 6 11.8 116.1 6 11.9 116.7 6 12.2 117.7 6 12.5 118.7 6 13.0 116.8 6 12.3 ,0.0001
Diastolic 73.2 6 9.1 73.7 6 9.3 74.3 6 9.3 74.9 6 9.6 75.5 6 9.7 74.3 6 9.4 ,0.0001
#140/90 mmHg (%) 15.0 17.3 21.2 20.8 25.7
Fasting glucose level
(mg/dL 6 SD) 87.3 6 6.6 87.6 6 6.7 87.7 6 6.7 87.8 6 6.7 88.1 6 7.0 87.7 6 6.7 ,0.0001
Cholesterol
(mg/dL 6 SD)
HDL 48.4 6 11.2 47.3 6 10.7 46.2 6 10.5 45.6 6 10.4 44.1 6 10.2 46.4 6 10.7 ,0.0001
LDL 111.6 6 31.4 115.0 6 31.6 116.2 6 32.1 118.6 6 33 121.0 6 34.6 116.3 6 32.6 ,0.0001
Triglycerides (mg/dL)
[25th, 75th] 97.1 [61, 116] 107.6 [67, 130] 119.2 [72, 145] 130.4 [78, 158] 145.7 [86, 178] 119.3 [88, 185] ,0.0001
Physical activity
.150 min/week (%) 8.1 8.3 8.4 7.4 6.1 7.7 ,0.0001
Family history of
diabetes (%) 12.0 13.6 12.8 12.7 14.7 13.1 0.3
Smoking (%) ,0.0001
Never 67.6 64.8 60.3 55.4 41.4 58.2
Former smoker 12.8 13.7 13.5 12.7 10.5 12.7
Current smoker 19.6 21.5 26.2 31.9 48.1 29.1
Lifestyle, physical, and biochemical characteristic data are presented for 24,897 normoglycemic subjects.
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WBC and diabetes incidence in young menparameters included in model 4 resulted
in an AUC of 0.674 (0.643–0.705) with-
out WBC and 0.676 (0.645–0.707) with
WBC. The change in 22 log likelihood
with addition of each of the variables to
the Cox regression model (omnibus test
of model coefﬁcients) revealed that BMI
and age had the highest contribution to
the model, followed by WBC count, fam-
ily history of diabetes, and triglycer-
ide level (Supplementary Table 2). As
detailed above, the upper one-third of
the WBC distribution (corresponding
to WBC levels .7,100 cells/mm
3)w a s
suggested as a potential threshold for in-
creaseddiabetesrisk.Indeed,asigniﬁcant
contribution to the full multivariate
model was observed when tertiles of
WBC (,5,900, 5,910–7,100, or $7,110
cells/mm
3)w e r eu s e d( P= 0.004 omnibus
test).
Ethnic variations in WBC count
Of the 24,897 subjects included in this
study, 7,939 were of African origin,
exhibiting a lower mean of WBC count
(5,510 6 1,440 cells/mm
3, P , 0.001)
than participants from non-African de-
scent. When WBC count was modeled
as a continuous variable, a signiﬁcant
11.8% increase in diabetes risk was ob-
served for every increment of 1,000
cells/mm
3 in this population (HR 1.118
[95%CI1.01–1.25],P=0.05).Thesedata
indicate that WBC count may be consid-
ered as a risk factor even among subjects
with a genetic tendency for a lower range
ofWBCcount(furtherdetailedinSupple-
mentary Table 3).
CONCLUSIONSdIn this prospec-
tive, large-scale study, we demonstrate
that a single measurement of WBC in
healthy, normoglycemic young men may
predict diabetes incidence independently
from the other traditional risk factors for
diabetes such as BMI, fasting glucose and
triglyceride levels, and family history. We
report that for every increase in 1,000
cells/mm
3 within the normal range of the
WBCcount,theriskfordiabetesincreases
by7.6%,andlevelsofWBCalreadyaslow
as 6,900 cells/mm
3 and above are associ-
ated with an obesity-independent ;50%
increase in the risk for diabetes. In addi-
tion, overweight and obese subjects
with a relatively low WBC count seem to
havea signiﬁcantlylower riskfordiabetes
than those with higher levels of leuko-
cytes, which may help in better charac-
terizing obese individuals who are
relatively protected from the metabolic
derangements frequently associated
with obesity.
Given the important role that has
been suggested for chronic inﬂammation
in obese states and its causal role in
mediating insulin resistance in peripheral
tissues (24), incorporating novel inﬂam-
matory markers into diabetes risk predic-
tion models has recently raised interest
(25–27). Assessment of the inﬂammatory
burden associated with obesity may con-
tribute to the interpretation of commonly
used clinical measurements of adiposity,
such as BMI, waist circumference, and
hip-to-thigh ratio, in determining the in-
ﬂammatory consequences of increased
adiposity and the risk for diabetes. In-
deed, many studies have demonstrated a
positive association between increased
levels of inﬂammatory markers, such as
W B Cc o u n t ,C R P ,a n di n ﬂammatory cy-
tokines, and diabetes incidence, although
only a few have tested this prospectively
in large, population-based studies (for a
systematic review and meta-analysis,
please see reference 18).
Previous studies have been inconsis-
tent in whether WBC or other inﬂamma-
tory markers contribute to diabetes
predictionmodelsindependentofobesity
(8,9,19–21) or whether these markers
simply reﬂect adipose tissue mass
(11,13,17,19). The current study, to the
best of our knowledge, is the largest
Table 2dHR for developing diabetes in normoglycemic patients across WBC quintiles
Quintile of WBC count
Total Q1 Q2 Q3 Q4 Q5
n =5 , 2 6 9 n =4 , 9 6 3 n =5 , 4 2 3 n =4 , 4 9 9 n =4 , 7 4 3 N = 24,897
WBC count (cells/mm
3)3 , 0 0 0 –5,400 5,401–6,180 6,181–6,900 6,901–7,800 7,801–12,000
New cases of diabetes, n 62 78 82 101 124 447
Mean follow-up (years 6 SD) 7.70 6 3.83 7.55 6 3.87 7.48 6 3.81 7.34 6 3.82 7.11 6 3.75 7.44 6 3.82
Person-years of follow-up 40,572 37,471 40,565 33,023 33,723 185,354
Model 1: Age adjusted
HR 1 1.36 1.34 1.99 2.44
95% CI 0.98–1.90 0.96–1.86 1.45–2.73 1.79–3.31
P 0.06 0.07 ,0.0001 ,0.0001 ,0.001
Model 2: Age and BMI adjusted
HR 1 1.25 1.10 1.54 1.68
95% CI 0.89–1.74 0.78–1.52 1.12–2.12 1.22–2.31
P 0.18 0.58 0.008 0.001 ,0.001
Model 3: Age, BMI, family history of diabetes, physical activity, smoking status adjusted
HR 1 1.23 1.11 1.55 1.62
95% CI 0.85–1.78 0.76–1.60 1.08–2.22 1.13–2.31
P 0.27 0.58 0.02 0.008 0.003
Model 4: Age, BMI, family history of diabetes, physical activity, smoking status, plasma triglycerides, fasting glucose adjusted
HR 1 1.22 1.07 1.48 1.52
95% CI 0.85–1.78 0.73–1.55 1.03–2.13 1.06–2.18
P 0.28 0.74 0.03 0.02 0.011
Cox regression multivariate analysis was used to derive the HR and 95% CI under different adjustments to lifestyle, physical, and biochemical parameters. Results in
each model refer to the lower WBC quintile. HR trend across WBC quintiles was calculated, and P value of trend is provided for each model.
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Twig and Associatescohort to address the potential role of
WBC as a common, widely available,
andsimplemethodtomeasureinﬂamma-
tory biomarker for diabetes prediction in
young adults. In the population studied,
elevated WBC count was not associated
with increased diabetes risk in lean, nor-
moglycemic men, a subgroup at a very
low risk for diabetes (total incidence of
0.90% for Q1 to 0.99% for Q5 during
;7.5 years for individuals with BMI
,25 kg/m
2,F i g .1 A). However, WBC
count was able to differentiate between
subgroups of overweight and obese
young men who are at a relatively low
risk (or even without an excess risk) for
diabetes and those who progressed to
overtdiabetesatsigniﬁcantlyhigherrates.
A potential explanation forthe lack of
predictive value of WBC count for di-
abetes incidence among men who are not
overweight or obese men is that WBC
count is a cumulative estimation of the
whole-body inﬂammatoryburden,which
reﬂects chronic as well as acute inﬂam-
matory processes. Adipose tissue inﬂam-
mation has mainly been attributed to
inﬂammatory processes observed in vis-
ceral and/or ectopic fat depositions, com-
partments whose relative mass is highly
increased in obesity (28). Therefore,
young, healthy, lean men, who have less
visceral and ectopic fat mass than obese
subjects, will be less likely to exhibit sig-
niﬁcant adiposetissueinﬂammation(29).
In this setting, and in the absence of
other recognized chronic inﬂammatory
processes, a relatively elevated WBC
count may represent more acute, inter-
current processes that do not seem to be
associated with a higher rate of diabetes
incidence. Indeed, Klöting et al. (30)
demonstratedthatvisceralbutnotsubcu-
taneous adipose tissue mass is associated
with insulin resistance independent
of BMI. Their results, as well as others
(31,32), emphasize that the body distri-
bution of fat, rather than cumulative fat
mass as denoted by BMI, is a principle
determinant of inﬂammation. In addi-
tion, the results of the current study sug-
gest that chronic, mild inﬂammation is an
importantandperhapsanecessarystepin
the progression of young adults to diabe-
tes, because subjects with low WBC
counts do not exhibit an excess risk for
incident diabetes, even in the presence of
excess weight, an elevated triglyceride
level,or apositive family history ofdiabe-
tes.
Several limitations of this study war-
rant consideration. First, the MELANY
cohort may be considered representative
of a unique group of healthy young men.
However, the characteristics of the pop-
ulation are strikingly similar to those of
cohorts in published studies of young
men from various industrialized coun-
tries (33–35). In addition, the relatively
homogeneous environment to which
participants in our study were exposed
might reduce the effect of unknown con-
founders. Second, measurements of waist
circumference,circulating insulin, and C-
peptide were not obtained in this study.
Although this did not compromise the
outcome deﬁnition, it limited our ability
to assess the role of insulin resistance in
the association between WBC count and
diabetes. Finally, we did not measure gly-
cosylated hemoglobin levels or perform
glucose-tolerance tests.
The current deﬁnition of normal FPG
levels resulted in a substantial increase in
the overlap with normal glucose toler-
ance, as deﬁned by glucose-tolerance
testing (36); however, we may have
missed men with normal FPG levels
whowerealreadyglucoseintolerantaten-
rollment.Tolimitthispossibility,wecon-
ﬁrmed our results by performing a
secondary analysis in which a 2-year lag
between enrollment and outcome was
used. Another point worth discussing is
the availably of only one WBC count
value at baseline, which may not accu-
rately represent the true inﬂammatory
burden in the presence of acute illnesses
or stresses. These potential false-positive
results, however, could have only under-
estimated the association of WBC count
with diabetes incidence.
The strengths of the MELANY study
include the detailed, uniform, and sys-
tematic follow-up and outcome deﬁni-
tion, the use of measured (rather than
reported) values for the BMI, the avail-
ability of reliable determinations of glu-
cose levels in fresh venous blood, and the
direct measurements of lipids.
The identiﬁcation of a high-normal
WBC count, measured in an outpatient
Figure 1dRisk factor for diabetes and WBC
count in young normoglycemic patients. Q1 to
Q5 indicate increment WBC quintiles as they
appear in Table 1. The dark bars indicate a sig-
niﬁcant change compared with the reference
group.A:JointeffectofBMIandWBCcountand
the risk for incident diabetes. Data are adjusted
for age, family history of diabetes, activity sta-
tus,smokingstatus,bloodpressure,triglycerides
level,andfastingglucose.Thereferencegroupis
in the lower WBC quintile at the lower (lean)
BMItertile.B:Jointeffectofplasmatriglycerides
(TG) level and WBC count and the risk for di-
abetes. Data are adjusted for age, BMI, family
history of diabetes, activity status, smoking
status,andfastingglucose.ReferencegroupisthelowerWBCquintileatanormal(,150mg/dL)TG
level. C: Joint effect of family history of diabetes, WBC count, and the risk for diabetes. Data are
adjusted for age, BMI of diabetes, activity status, smoking status, triglycerides level, and fasting
glucose. Reference group is the lower WBC quintile without a family history of diabetes.
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diabetes in addition to the other known
risk factors may elaborate the interpreta-
tion of this commonly used laboratory
test by primary care providers, increasing
their attention to increased diabetes risk
among young adults, who are usually not
frequently screened for this condition.
Identifying individuals at higher risk for
diabetes may facilitate the consideration
of preventive interventions. Indeed, life-
style and pharmacological approaches
have both been reported to be efﬁcient
in delaying the onset of diabetes in se-
lected groups at high risk for the disease
(37–40). Of speciﬁc interest is the obser-
vation that speciﬁca n t i - i n ﬂammatory
treatments for rheumatoid arthritis pa-
tients also resulted in a decreased inci-
dence of diabetes (6). Targeting the
obesity-related chronic inﬂammatory re-
sponse to prevent the metabolic derange-
ments associated with increased fat
deposition may become an attractive ap-
proachfordiabetespreventiononceaddi-
tional, more speciﬁc anti-inﬂammatory
treatments with more tolerated side ef-
fects become available.
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